Open in app

Sign in

Write

Sign in

Nucleate
Nucleate

177 followers

Home

About

Meet the 197 Biotech Ventures in Nucleate’s 2025 Activator Program

Nucleate, the nonprofit organization committed to empowering the next generation of biotech leaders, proudly announces the selection of 197…

Apr 16
Meet the 197 Biotech Ventures in Nucleate’s 2025 Activator Program
Meet the 197 Biotech Ventures in Nucleate’s 2025 Activator Program
Apr 16

Nucleate Announces Expansion of Eli Lilly and Company Grand Challenge to include Women’s Health

BOSTON, MA– 4/2/2025 — ​​Nucleate today announced the expansion of the Eli Lilly and Company Grand Challenge, now in its third year, to…

Apr 2
Nucleate Announces Expansion of Eli Lilly and Company Grand Challenge to include Women’s Health
Nucleate Announces Expansion of Eli Lilly and Company Grand Challenge to include Women’s Health
Apr 2

Nucleate Announces the Launch of the 2025 Nucleate Venture Fellowship, in Partnership with Pillar…

Nucleate, the global non-profit organization dedicated to empowering the next generation of biotech leaders, announced the renewal of its…

Feb 19
Nucleate Announces the Launch of the 2025 Nucleate Venture Fellowship, in Partnership with Pillar…
Nucleate Announces the Launch of the 2025 Nucleate Venture Fellowship, in Partnership with Pillar…
Feb 19

Nucleate Announces Appointments of a CEO and COO

[Boston, Massachusetts — January 9th, 2025]

Jan 9
Nucleate Announces Appointments of a CEO and COO
Nucleate Announces Appointments of a CEO and COO
Jan 9

Innovation in Action: Highlights from the 2024 Eli Lilly and Company Grand Challenge

The 2024 Eli Lilly and Company Grand Challenge has wrapped up, and it’s been an exciting opportunity to spotlight innovation in genetic…

Dec 18, 2024
Innovation in Action: Highlights from the 2024 Eli Lilly and Company Grand Challenge
Innovation in Action: Highlights from the 2024 Eli Lilly and Company Grand Challenge
Dec 18, 2024

Nucleate Announces a Three Year Partnership with ARIA in the UK

Nucleate, the non-profit organization dedicated to empowering the next generation of biotech leaders, announced a new partnership with the…

Oct 9, 2024
Nucleate Announces a Three Year Partnership with ARIA in the UK
Nucleate Announces a Three Year Partnership with ARIA in the UK
Oct 9, 2024

Nucleate Publishes Student-Led Review on Spider Silk Bioproduction Offers Comprehensive Insights…

A first-of-its-kind student-led research initiative on the potential and feasibility of spider silk bioproduction has been published in ACS…

Aug 22, 2024
Nucleate Publishes Student-Led Review on Spider Silk Bioproduction Offers Comprehensive Insights…
Nucleate Publishes Student-Led Review on Spider Silk Bioproduction Offers Comprehensive Insights…
Aug 22, 2024

Nucleate Announces First Impact Report: 5 Years of Nucleate

Nucleate, the nonprofit organization led by academic trainees and dedicated to empowering future biotech leaders, released its first impact…

Aug 21, 2024
Nucleate Announces First Impact Report: 5 Years of Nucleate
Nucleate Announces First Impact Report: 5 Years of Nucleate
Aug 21, 2024

Nucleate Announces Leadership Transition from Samantha Sison and Michael Retchin to Heer Joisher…

Nucleate, the nonprofit organization dedicated to empowering the next generation of biotech leaders, is pleased to announce the appointment…

Aug 13, 2024
Nucleate Announces Leadership Transition from Samantha Sison and Michael Retchin to Heer Joisher…
Nucleate Announces Leadership Transition from Samantha Sison and Michael Retchin to Heer Joisher…
Aug 13, 2024

Nucleate Launches Second Entrepreneurial Scientist Playbook on Operationalizing Your Therapeutics…

Nucleate, the 501(c)(3) nonprofit organization dedicated to empowering tomorrow’s biotech leaders by educating today’s academic trainees…

Aug 6, 2024
Nucleate Launches Second Entrepreneurial Scientist Playbook on Operationalizing Your Therapeutics…
Nucleate Launches Second Entrepreneurial Scientist Playbook on Operationalizing Your Therapeutics…
Aug 6, 2024
Nucleate

Nucleate

177 followers

Help

Status

About

Careers

Press

Blog

Privacy

Rules

Terms

Text to speech